Senate Committee says it is investigating a conduct allegation raised about Crawford. Disclosure has the hallmarks of an attempt to torpedo the nomination – and helps shift debate over Crawford away from FDA's handling of Barr emergency contraceptive.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
The budget authority total, which is significantly higher than the amount floated in an April OMB draft document, suggests there may have been successful lobbying to increase FDA funding.
In this first in a series of articles looking at the potential impact of the MFN drug pricing policy on European pharmaceutical markets, EUCOPE’s Alexander Natz tells the Pink Sheet why the US policy underscores the importance of confidential net pricing.
The International Council for Harmonisation has identified four new topics that can benefit from global regulatory alignment, with timelines for initiating work to be determined later.
